Design and synthesis of novel CCR3 antagonists

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

As part of our investigation into the development of potent CCR3 antagonists, a series of piperidine analogues was designed and prepared. Exploration of the piperidine core examined both the basicity and the location of a nitrogen, as well as conformational variants. The bicyclo-piperidine 24c was found to be the most potent inhibitor of CCR3 with an IC(50) of 0.0082 microM in the binding assay and 0.0024 microM in the chemotaxis assay.

Knowledge Graph

Similar Paper

Design and synthesis of novel CCR3 antagonists
Bioorganic & Medicinal Chemistry Letters 2003.0
Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
Bioorganic & Medicinal Chemistry Letters 2001.0
Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1
Bioorganic & Medicinal Chemistry Letters 2001.0
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles
Bioorganic & Medicinal Chemistry Letters 2010.0
Piperidine variations in search for non-imidazole histamine H3 receptor ligands
Bioorganic & Medicinal Chemistry 2008.0
trans -3,4-Dimethyl-4-(3-carboxamidophenyl)piperidines: A novel class of μ-Selective opioid antagonists
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT2C agonists
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and structure–activity relationship of benzetimide derivatives as human CXCR3 antagonists
Bioorganic & Medicinal Chemistry Letters 2008.0
Cyclohexylmethylpiperidinyltriphenylpropioamide:  A Selective Muscarinic M<sub>3</sub> Antagonist Discriminating against the Other Receptor Subtypes
Journal of Medicinal Chemistry 2002.0